In addition to being less effective, we also obtained indications that VIP administration during the latter period of infection had negative effects: two out of four mice receiving VIP during this period died, and although we have no hard data on this, the other mice in this group appeared less active than non-treated mice. The gene discussed is VIP; the disease is infection.